Recordati signs licensing agreement with Amarin to commercialize cardiovascular medicine, Vazkepa in Europe
Recordati, an international pharmaceutical group listed on the Italian Stock Exchange with a family-run pharmacy in Northern Italy, announced a licensing and supply agreement with Amarin to commercialize the marketed cardiovascular medicine, Vazkepa ( …